A Highly Sensitive Graphene-based Field Effect Transistor for the Detection of Myoglobin

22Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Biomedical applications adapt Nano technology-based transistors as a key component in the biosensors for diagnosing life threatening diseases like Covid-19, Acute myocardial infarction (AMI), etc. The proposed work introduces a new biosensor, based on Graphene Field Effect Transistor (GFET), which is used in the diagnosis of Myoglobin (Mb) in human blood. Graphene-based biosensors are faster, more precise, stronger, and more trustworthy. A GFET is created in this study for the detection of myoglobin biomarker at various low concentrations. Because graphene is sensitive to a variety of biomarker materials, it can be employed as a gate material. When constructed Graphene FET is applied to myoglobin antigens, it has a significant response. The detection level for myoglobin is roughly 30 fg/ml, which is quite high. The electrical behavior of the GFET-based biosensor in detecting myoglobin marker is ideal for Lab-on-Chip platforms and Cardiac Point-of-Care Diagnosis.

Cite

CITATION STYLE

APA

Krsihna, B. V., Gangadhar, A., Ravi, S., Mohan, D., Panigrahy, A. K., Rajeswari, V. R., & Prakash, M. D. (2022). A Highly Sensitive Graphene-based Field Effect Transistor for the Detection of Myoglobin. Silicon, 14(17), 11741–11748. https://doi.org/10.1007/s12633-022-01790-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free